Affordable Access

Adaptation of Cognitive Behavioral Analysis System of Psychotherapy in a 29 Year Old Female Patient with Chronic Major Depression and Antecedent Dysthymic Disorder Who Switched Under Combined SSRI/CBASP Outpatient Treatment into Bipolarity: A Case Report

Authors
Publication Date
Keywords
  • Ddc:610
Disciplines
  • Medicine

Abstract

Microsoft Word - 08_Oertel Knocher _final.docx Chapter 8 © 2013 Oertel-Knöchel and Schoepf, licensee InTech. This is an open access chapter distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Adaptation of Cognitive Behavioral Analysis System of Psychotherapy in a 29 Year Old Female Patient with Chronic Major Depression and Antecedent Dysthymic Disorder Who Switched Under Combined SSRI/CBASP Outpatient Treatment into Bipolarity: A Case Report Viola Oertel-Knöchel and Dieter Schoepf Additional information is available at the end of the chapter http://dx.doi.org/10.5772/51963 1. Introduction Affective disorders are among the main psychiatric illnesses reaching from major depressive disorder (MDD) and bipolar disorder (BD) to schizoaffective disorder. Under a historical perceptive, the beginning of the conceptualisation of affective disorders was done in 1854, when Jean-Pierre Falret named recurrent episodes of mania and depression as folie circulaire (Sedler & Falret, 1983). This was followed by Emil Kraepelin’s definition as manic-depressive psychosis, which include the observation by Kraepelin that symptom-free intervals and acute illness episodes alternates in these patients (Kraepelin, 1921). A categorical distinction between two spectra with different diseases and different clinical courses, i.e. the unipolar spectrum and the bipolar spectrum, was first introduced by Karl Leonhard in 1957 (Beckmann, 1999). With respect to the unipolar spectrum, MDD is among the most debilitating diseases worldwide with high disability compared with all human diseases (Falagas, Vardakas, & Vergidis, 2007). Lifetime prevalence of MDD is up to 20% once a life (Williams et al., 2007). In one third of the cases, the course of the illness is chronic, with of

There are no comments yet on this publication. Be the first to share your thoughts.